In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profile and elicited a robust immune response
Background: An investigational subunit vaccine containing the varicella-zoster virus (VZV) glycoprot...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background: This study investigated the safety and immunogenicity of different formulations and sche...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profi...
A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vac...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. An adjuvanted varicella-zoster virus glycoprotein E (gE) subunit vaccine candidate for h...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background: An investigational subunit vaccine containing the varicella-zoster virus (VZV) glycoprot...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background: This study investigated the safety and immunogenicity of different formulations and sche...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella...
glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profi...
A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vac...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycopro...
Background. An adjuvanted varicella-zoster virus glycoprotein E (gE) subunit vaccine candidate for h...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background: An investigational subunit vaccine containing the varicella-zoster virus (VZV) glycoprot...
Background. An adjuvanted recombinant varicella zoster virus (VZV) subunit vaccine is being develope...
Background: This study investigated the safety and immunogenicity of different formulations and sche...